Human secretory leucocyte proteinase inhibitor (SLPI) is a low-molecular weight, acid-stable inhibitor of polymorphnuclear granulocyte elastase and cathepsin G. Previous reports have demonstrated the existence of SLPI in the respiratory tract, salivary glands and cervical mucosa. Positive staining for SLPI using immunohistochemical techniques has been reported in serous glands in nasal mucosa. We now confirm this observation and show, using in situ hybridization, that the pattern of expression of mRNA corresponds to the distribution of the encoded protein, SLPI. This, together with the high concentration of SLPI in nasal secretions, confirms the hypothesis of a local production of SLPI in the mucous membranes
Secretory Leukocyte Peptidase Inhibitor (SLPI) functionality in health and disease: Secretory Leukoc...
Secretory leukoprotease inhibitor (SLPI) is a low molecular weight serine protease inhibitor found o...
Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respirat...
Human secretory leucocyte proteinase inhibitor (SLPI) is a low-molecular weight, acid-stable inhibit...
In this study we demonstrated the production of SLPI (Secretory Leukocyte Protease Inhibitor) in ser...
Recently interest has been focused on secretory leucocyte protease inhibitor (SLPI) and its role in ...
The secretory leucocyte proteinase inhibitor (SLPI) is a low molecular weight, tissue-specific inhib...
The immune system is continuously challenged with large quantities of exogenous antigens at the barr...
SUMMARY AT A GLANCE: Secretory leukocyte proteinase inhibitor (SLPI) is a major anti-elastase barrie...
The secretory leukocyte protease inhibitor (SLPI) is a low-molecular- weight inhibitor of proteases,...
ABSTRACT: Secretory leucocyte protease inhibitor, SLPI, is a low‐molecular‐weight, acid‐stable prote...
Secretory leukocyte protease inhibitor is a 11.7 kDa acid stable serine protease inhibitor. SLPI has...
Secretory leukocyte protease inhibitor (SLPI) is a well-known protease inhibitor. Its function is th...
Secretory leukoprotease inhibitor (SLPI) is a low molecular weight serine protease inhibitor found o...
Bronchial leucocyte proteinase inhibitor (BLPI) is an 11 000 M(r) protein found in human mucous secr...
Secretory Leukocyte Peptidase Inhibitor (SLPI) functionality in health and disease: Secretory Leukoc...
Secretory leukoprotease inhibitor (SLPI) is a low molecular weight serine protease inhibitor found o...
Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respirat...
Human secretory leucocyte proteinase inhibitor (SLPI) is a low-molecular weight, acid-stable inhibit...
In this study we demonstrated the production of SLPI (Secretory Leukocyte Protease Inhibitor) in ser...
Recently interest has been focused on secretory leucocyte protease inhibitor (SLPI) and its role in ...
The secretory leucocyte proteinase inhibitor (SLPI) is a low molecular weight, tissue-specific inhib...
The immune system is continuously challenged with large quantities of exogenous antigens at the barr...
SUMMARY AT A GLANCE: Secretory leukocyte proteinase inhibitor (SLPI) is a major anti-elastase barrie...
The secretory leukocyte protease inhibitor (SLPI) is a low-molecular- weight inhibitor of proteases,...
ABSTRACT: Secretory leucocyte protease inhibitor, SLPI, is a low‐molecular‐weight, acid‐stable prote...
Secretory leukocyte protease inhibitor is a 11.7 kDa acid stable serine protease inhibitor. SLPI has...
Secretory leukocyte protease inhibitor (SLPI) is a well-known protease inhibitor. Its function is th...
Secretory leukoprotease inhibitor (SLPI) is a low molecular weight serine protease inhibitor found o...
Bronchial leucocyte proteinase inhibitor (BLPI) is an 11 000 M(r) protein found in human mucous secr...
Secretory Leukocyte Peptidase Inhibitor (SLPI) functionality in health and disease: Secretory Leukoc...
Secretory leukoprotease inhibitor (SLPI) is a low molecular weight serine protease inhibitor found o...
Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respirat...